A detailed history of Wimmer Associates 1, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 10,590 shares of PFE stock, worth $283,176. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,590
Previous 10,497 0.89%
Holding current value
$283,176
Previous $293,000 4.44%
% of portfolio
0.15%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $2,576 - $2,919
93 Added 0.89%
10,590 $306,000
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $9,624 - $11,277
381 Added 3.77%
10,497 $293,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $19,106 - $21,940
738 Added 7.87%
10,116 $280,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $222,653 - $289,202
-8,521 Reduced 47.61%
9,378 $269,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $206,049 - $240,851
-6,421 Reduced 26.4%
17,899 $593,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $11,811 - $13,665
-327 Reduced 1.33%
24,320 $892,000
Q1 2023

May 16, 2023

SELL
$39.39 - $51.28 $60,660 - $78,971
-1,540 Reduced 5.88%
24,647 $1.01 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $9,185 - $11,990
-220 Reduced 0.83%
26,187 $1.34 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $77,805 - $94,980
-1,778 Reduced 6.31%
26,407 $1.23 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $12,795 - $15,171
275 Added 0.99%
28,185 $1.48 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $203,816 - $252,553
4,455 Added 18.99%
27,910 $1.45 Million
Q4 2021

Feb 16, 2022

BUY
$41.32 - $61.25 $71,896 - $106,575
1,740 Added 8.01%
23,455 $1.39 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $66,254 - $85,108
1,688 Added 8.43%
21,715 $934,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $76,667 - $86,851
2,135 Added 11.93%
20,027 $784,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $96,585 - $108,928
2,884 Added 19.22%
17,892 $648,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $53,418 - $67,925
1,596 Added 11.9%
15,008 $552,000
Q3 2020

Dec 03, 2020

BUY
$31.75 - $37.25 $22,987 - $26,969
724 Added 5.71%
13,412 $492,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $31,686 - $38,440
1,052 Added 9.04%
12,688 $487,000
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $47,816 - $68,318
1,769 Added 17.93%
11,636 $380,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $164 - $186
5 Added 0.05%
9,867 $387,000
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $3,606 - $4,676
-111 Reduced 1.11%
9,862 $354,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $7,248 - $8,137
-196 Reduced 1.93%
9,973 $432,000
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $150 - $164
4 Added 0.04%
10,169 $432,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $11,656 - $13,289
303 Added 3.07%
10,165 $444,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $13,064 - $15,845
379 Added 4.0%
9,862 $435,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $131 - $140
4 Added 0.04%
9,483 $344,000
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $16,561 - $19,213
519 Added 5.79%
9,479 $336,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $9,944 - $10,551
299 Added 3.45%
8,960 $325,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $9,734 - $10,723
314 Added 3.76%
8,661 $309,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,347
8,347 $280,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wimmer Associates 1, LLC Portfolio

Follow Wimmer Associates 1, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.